Biosimilars onkowissen is made and published by onkowissen.de GmbH. AppBrain is an independent app data site and isn't affiliated with onkowissen.de GmbH. The app name, icon, screenshots and description belong to onkowissen.de GmbH and are shown as published on the App Store.
About Biosimilars onkowissen
Biosimilars onkowissen was a medical app developed by onkowissen.de GmbH. It was removed from the App Store Apr 27, 2025.
User Ratings
The app had no ratings.
App Information
Biosimilars onkowissen was free. The app size was 57.19 MB. The last available version was 3.2. The last update was on June 28, 2023.
Technical Requirements
The app had a content rating of High Maturity. The app had been available on the App Store since June 2018.
Similar apps
Screenshots
Also available on Google Play
More from onkowissen.de GmbH
Changelog of Biosimilars onkowissen
No changelog data
Developer information for onkowissen.de GmbH
Address:
Comments on Biosimilars onkowissen for iOS
We don't have enough comments to show example comments. Please check back later.
Technologies used by Biosimilars onkowissen
Frequently asked questions about Biosimilars onkowissen
Is Biosimilars onkowissen free?
Yes. Biosimilars onkowissen is free on the App Store.
Is Biosimilars onkowissen still available?
No. Biosimilars onkowissen was removed from the App Store. We last saw it there Apr 27, 2025.
How large is Biosimilars onkowissen?
Biosimilars onkowissen is 57.19 MB.
Is Biosimilars onkowissen suitable for children?
App Store gives Biosimilars onkowissen a high maturity rating. It is meant for adults.
Who made Biosimilars onkowissen?
Biosimilars onkowissen was developed by onkowissen.de GmbH. It is listed in the medical category on the App Store.
What are the best alternatives to Biosimilars onkowissen?
People looking at Biosimilars onkowissen also look at these medical apps: mymobility Patient App, Health Stats: Fitness Tracker, Yoga for Weight Loss | Nandy, Organic Dance: Weight Loss App, Pulsebit: Heart Rate Monitor.